Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03567525
Other study ID # HHC-2018-0115
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 14, 2018
Est. completion date July 8, 2022

Study information

Verified date August 2022
Source Hartford Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Lymphoceles are a potentially serious complication of radical prostatectomy (RP) with pelvic lymph node dissection. They are associated with abdominal pain, urinary tract symptoms, fever, lower extremity swelling and deep vein thrombosis. They can be severe enough to necessitate intervention in 5% of patients after RRP with PLND, with sequela that could include infection and nerve damage. Studies evaluating strategies to preclude lymphocele formation after RP have included comparisons of the use of titanium clips vs bipolar coagulation to seal lymphatic vessels during pelvic lymph node dissection. In a recent prospective randomized trial comparing these approaches, no differences were observed in the rates of lymphocele formation as detected by ultrasound. There is a need to continue to test potential strategies to minimize the formation of lymphoceles after RRP. Creation of a peritoneal iliac flap is one approach has potential towards this end. At the Lahey Hospital and Medical Center in Burlington, MA surgeons routinely fold the bladder into a peritoneal flap to overlay the area of extended lymphadenectomy. It is thought that this method prevents the formation of lymphoceles because the flap creates a window, which allows drainage of the lymph fluid into the peritoneal cavity to be reabsorbed. While the Lahey study supports the safety and effectiveness of the peritoneal flap approach, the procedure has never been evaluated through a randomized prospective trial and the practice is certainly not standard of care. We therefore propose a randomized, prospective clinical trial to be conducted in the Hartford Hospital Urology Department to examine the effectiveness of a peritoneal iliac flap on the formation of lymphoceles after RRP with pelvic lymph node dissection. Hypotheses: 1. We hypothesize that, at 3 months after RP, rates of lymphocele formation (symptomatic and asymptomatic lymphoceles) will be significantly lower in patients who have pelvic lymph node dissection using the peritoneal iliac flap approach than in patients who have pelvic lymph node dissection using the standard approach. 2. Lymphoceles are often associated with lower urinary tract symptoms. We hypothesize that, after RP, severity of urinary bother symptoms and urinary incontinence will be significantly lower at each measurement period for patients who had pelvic lymph node dissection using the peritoneal iliac flap approach relative to patients who had pelvic lymph node dissection using the standard approach.


Recruitment information / eligibility

Status Completed
Enrollment 225
Est. completion date July 8, 2022
Est. primary completion date January 11, 2022
Accepts healthy volunteers No
Gender Male
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - scheduled to undergo robotic assisted radical prostatectomy with pelvic lymph node dissection for prostate cancer at Hartford Hospital. - diagnosed with biopsy-proven prostate cancer, with intermediate or high risk features per D'Amico risk stratification - ability to give informed consent to participate in the study Exclusion Criteria: - Patients with prior prostate irradiation and peri-aortic lymph node dissections will be excluded

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
lymph node dissection using the peritoneal iliac flap approach to seal lymphatic vessels
After pelvic lymph node dissection, lymphatic vessels will be sealed by formation of a peritoneal iliac flap in which the bladder in folded over the area of lymph node dissection
Standard surgical approach
After pelvic lymph node dissection, lymphatic vessels will be sealed using the standard approach

Locations

Country Name City State
United States Hartford Hospital Hartford Connecticut

Sponsors (1)

Lead Sponsor Collaborator
Hartford Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Lymphocele formation Formation of a least one lymphocele as detected by pelvic ultrasound 3 months after surgery 3 months
See also
  Status Clinical Trial Phase
Completed NCT06284135 - MICHL-trial: Impact of Peritoneal Bladder Flap in RARP Patients on Lymphoceles N/A
Terminated NCT03006562 - PREvention of VENous ThromboEmbolism Following Radical Prostatectomy Phase 4
Completed NCT04205864 - Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer. N/A
Completed NCT04853095 - Effect of Peritoneal Fixation on Lymphocele Formation N/A